Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
J Infect Dev Ctries ; 15(1): 172-178, 2021 01 31.
Artigo em Inglês | MEDLINE | ID: mdl-33571161

RESUMO

Transplanted patients are particularly exposed to a major risk of infectious diseases due to prolonged immunosuppressive treatment. Over the last decade, the growing migration flows and the transplant tourism have led to increasing infections caused by geographically restricted organisms. Malaria is an unusual event in organ transplant recipients than can be acquired primarily or reactivation following immunosuppression, by transfusion of blood products or through the transplanted organ. We report a rare case of Plasmodium falciparum infection in a liver transplanted two years-old African boy who presented to one Italian Asylum Seeker Center on May 2019. We outlined hereby diagnostic challenges, possible aetiologies of post-transplantation malaria and finally we summarized potential drug interactions between immunosuppressive agents and antimalarials. This report aims to increase the attention to newly arrived migrants, carefully evaluating patients coming from tropical areas and taking into consideration also rare tropical infections not endemic in final destination countries.


Assuntos
Malária Falciparum/diagnóstico , Antimaláricos/uso terapêutico , Artemeter/uso terapêutico , Artesunato/uso terapêutico , Pré-Escolar , Humanos , Transplante de Fígado/efeitos adversos , Lumefantrina/uso terapêutico , Malária Falciparum/tratamento farmacológico , Masculino , Plasmodium falciparum/parasitologia , Migrantes , Transplantados , Resultado do Tratamento
2.
Parasitol Int ; 75: 102006, 2020 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-31676328

RESUMO

BACKGROUND: Loiasis is a vector-borne parasitic infection endemic across many areas of Central and West Africa. Its treatment is tricky due to the risk of serious neurologic adverse events occurring after the administration of microfilaricidal drugs, like diethylcarbamazine or ivermectin, in subjects with high pre-treatment microfilarial load. Albendazole is currently recommended to slowly reduce microfilaremia before curative regimen is prescribed. CASE PRESENTATION: We report the case of a 25-year-old man from Guinea-Conakry who was incidentally diagnosed with highly microfilaremic Loa loa infection. A three weeks regimen of albendazole was prescribed. Minor neurologic side effects occurred after two weeks of administration, while serious encephalopathy developed one week later. Clinical and electroencephalographic features of the patient resembled those of an immune-mediated encephalitis. After exclusion of other causes of encephalopathy, treatment-related Loa loa encephalopathy induced by albendazole was suspected. Corticosteroid treatment was administered and the patient recovered. DISCUSSION: Our case confirms that Loa loa treatment-related encephalopathy may occur even during albendazole treatment. The clinical and electroencephalographic similarities between Loa loa albendazole-related encephalopathy and immune-mediated encephalitis suggest the possibility of an underlying inflammation-based pathogenesis. Although corticosteroid administration is not recommended in Loa loa ivermectin-induced encephalopathy, in this case of Loa loa albendazole-induced encephalopathy it may have played a therapeutic role.


Assuntos
Albendazol/efeitos adversos , Filaricidas/efeitos adversos , Loa/isolamento & purificação , Loíase/tratamento farmacológico , Corticosteroides/uso terapêutico , Adulto , Albendazol/uso terapêutico , Animais , Diagnóstico Diferencial , Filaricidas/uso terapêutico , Guiné , Humanos , Itália , Loa/crescimento & desenvolvimento , Masculino , Microfilárias/isolamento & purificação , Resultado do Tratamento
3.
BMC Infect Dis ; 19(1): 876, 2019 Oct 22.
Artigo em Inglês | MEDLINE | ID: mdl-31640585

RESUMO

BACKGROUND: Blastocystis is one of the most common intestinal protozoa in human faecal samples with uncertain impact on public health. Studies on the prevalence of Blastocystis in HIV-positive patients are limited and dated. METHODS: A cross-sectional study was carried out involving 156 HIV-positive patients to evaluate the prevalence of Blastocystis-subtypes by molecular amplification and sequencing the small subunit rRNA gene (SSU rDNA), to identify the risk factors for its transmission, to examine the relationship between the presence of the protist and gastrointestinal disorders. Furthermore, the evaluation of the faecal calprotectin by immunoassay from a sample of subjects was performed to evaluate the gut inflammation in Blastocystis-carriers. RESULTS: Blastocystis-subtypes ST1, ST2, ST3, ST4 were identified in 39 HIV-positive patients (25%). No correlation was found between the presence of the protist and virological or epidemiological risk factors. Blastocystis was more frequently detected in homosexual subjects (p = 0.037) infected by other enteric protozoa (p = 0.0001) and with flatulence (p = 0.024). No significant differences in calprotectin level was found between Blastocystis-carriers and free ones. CONCLUSIONS: Blastocystis is quite common in HIV-positive patients on ART showing in examined patients 25% prevalence. Homosexual behaviour may represent a risk factor for its transmission, while CD4 count and viremia didn't correlate with the presence of the protist. The pathogenetic role of Blastocystis remains unclear and no gut inflammation status was detected in Blastocystis-carriers. The only symptom associated with Blastocystis was the flatulence, evidencing a link between the presence of the protist and the composition and stability of gut microbiota.


Assuntos
Infecções por Blastocystis/epidemiologia , Blastocystis/patogenicidade , Soropositividade para HIV/parasitologia , Infecções Oportunistas Relacionadas com a AIDS/epidemiologia , Infecções Oportunistas Relacionadas com a AIDS/parasitologia , Adulto , Idoso , Animais , Animais Domésticos , Blastocystis/genética , Infecções por Blastocystis/etiologia , Infecções por Blastocystis/transmissão , Estudos Transversais , Fezes/química , Fezes/parasitologia , Feminino , Soropositividade para HIV/tratamento farmacológico , Homossexualidade Masculina , Humanos , Complexo Antígeno L1 Leucocitário/análise , Masculino , Pessoa de Meia-Idade , Filogenia , Prevalência , Fatores de Risco , Adulto Jovem
4.
Infection ; 46(5): 725-727, 2018 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-29946850

RESUMO

INTRODUCTION: Hepatitis E virus (HEV) is an emerging cause of autochthonous-acute-hepatitis and acute-on-chronic-liver-failure in western countries. Treatment is not routinely used, despite ribavirin has a good antiviral effect. In vitro sofosbuvir inhibits HEV replication, but clinical data are lacking. CASE REPORT: We report a case of acute-on-chronic-liver-failure due to HEV treated with sofosbuvir and ribavirin. The treatment was capable of rapidly inducing both HCV and HEV viral suppression. CONCLUSION: In conclusion, although more data are required before firm conclusions could be drawn, the combination of sofosbuvir and ribavirin in not immunosuppressed patients with acute hepatitis E may be able to clear HEV infection.


Assuntos
Hepatite E/tratamento farmacológico , Hepatite E/transmissão , Ribavirina/uso terapêutico , Sofosbuvir/uso terapêutico , Insuficiência Hepática Crônica Agudizada/diagnóstico , Insuficiência Hepática Crônica Agudizada/tratamento farmacológico , Insuficiência Hepática Crônica Agudizada/virologia , Biomarcadores , Coinfecção , Quimioterapia Combinada , Evolução Fatal , Hepatite E/diagnóstico , Hepatite E/virologia , Humanos , Testes de Função Hepática , Masculino , Pessoa de Meia-Idade , Ribavirina/administração & dosagem , Choque Séptico , Sofosbuvir/administração & dosagem , Resultado do Tratamento , Carga Viral
5.
Eur J Intern Med ; 36: 74-80, 2016 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-27727076

RESUMO

BACKGROUND: Community-acquired pneumonia (CAP) is complicated by cardiovascular events as myocardial infarction and stroke but the underlying mechanism is still unclear. We hypothesized that endothelial dysfunction may be implicated and that endotoxemia may have a role. METHODS: Fifty patients with CAP and 50 controls were enrolled. At admission and at discharge, flow-mediated dilation (FMD), serum levels of endotoxins and oxidative stress, as assessed by serum levels of nitrite/nitrate (NOx) and isoprostanes, were studied. RESULTS: At admission, a significant difference between patients with CAP and controls was observed for FMD (2.1±0.3 vs 4.0±0.3%, p<0.001), serum endotoxins (157.8±7.6 vs 33.1±4.8pg/ml), serum isoprostanes (341±14 vs 286±10 pM, p=0.009) and NOx (24.3±1.1 vs 29.7±2.2µM). Simple linear correlation analysis showed that serum endotoxins significantly correlated with Pneumonia Severity Index score (Rs=0.386, p=0.006). Compared to baseline, at discharge CAP patients showed a significant increase of FMD and NOx (from 2.1±0.3 to 4.6±0.4%, p<0.001 and from 24.3±1.1 to 31.1±1.5µM, p<0.001, respectively) and a significant decrease of serum endotoxins and isoprostanes (from 157.8±7.6 to 55.5±2.3pg/ml, p<0.001, and from 341±14 to 312±14 pM, p<0.001, respectively). Conversely, no changes for FMD, NOx, serum endotoxins and isoprostanes were observed in controls between baseline and discharge. Changes of FMD significantly correlated with changes of serum endotoxins (Rs=-0.315; p=0.001). CONCLUSIONS: The study provides the first evidence that CAP is characterized by impaired FMD with a mechanism potentially involving endotoxin production and oxidative stress.


Assuntos
Infecções Comunitárias Adquiridas/fisiopatologia , Endotélio Vascular/fisiopatologia , Isoprostanos/sangue , Lipopolissacarídeos/sangue , Nitratos/sangue , Nitritos/sangue , Pneumonia/fisiopatologia , Vasodilatação , Idoso , Idoso de 80 Anos ou mais , Artéria Braquial/diagnóstico por imagem , Artéria Braquial/fisiopatologia , Infecções Comunitárias Adquiridas/sangue , Feminino , Hospitalização , Humanos , Masculino , Pessoa de Meia-Idade , Estresse Oxidativo , Pneumonia/sangue , Estudos Prospectivos , Ultrassonografia
6.
BMC Infect Dis ; 16: 248, 2016 06 06.
Artigo em Inglês | MEDLINE | ID: mdl-27266512

RESUMO

BACKGROUND: Human dirofilariosis is still a little known infection even in endemic areas. Dirofilariosis is zoonotic infection usually abortive in humans; instead, we report a very rare case (the 4th in the world), the first in Italy, in which at least two infective larvae became mature adults that mated and produced active microfilariae even though they did not reach peripheral blood. CASE PRESENTATION: A 30-year-old Italian woman presented with a transient oedematous swelling on the left abdominal wall with a creeping eruption followed by the occurrence of a subcutaneous nodular painless mass in the iliac region. One month later, a similar temporary swelling appeared on the contralateral inguinal region associated with intermittent joint discomfort in both knees. The patient had recently travelled abroad, therefore many possible diagnoses were to be ruled out. Routine laboratory investigations revealed eosinophilia. An ultrasound examination of the iliac swelling evidenced a well-defined cyst with a big filamentous formation in continuous movement. A fine-needle aspiration of the lesion was performed for parasitological, cytological and histological exams. The prompt microscopic examination of the aspired material showed the presence of numerous microfilariae that were initially morphologically attributed to Mansonella ozzardi. Subsequently, the revision of the Giemsa stained film and molecular analyses of the biological material, allowed to identify Dirofilaria repens as etiological agent of infection. CONCLUSIONS: We report of a case in whom microfilariae were detected in fine-needle aspirate of subcutaneous node, without evidence of microfilaraemia, and the infection failed to become fully patent. Therefore we confirm that complete development and fertilization of D. repens worms in human hosts may occur, at variance with what is commonly believed, that Dirofilaria worms cannot fully develop in humans.


Assuntos
Dirofilaria repens/isolamento & purificação , Dirofilariose/diagnóstico , Linfonodos/parasitologia , Mansonelose/diagnóstico , Microfilárias , Adulto , Animais , Biópsia por Agulha Fina , Diagnóstico Diferencial , Dirofilaria repens/genética , Feminino , Humanos , Itália , Mansonella , Agulhas , Reação em Cadeia da Polimerase
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA